Advertisement
Jupiter Neurosciences Inc... (JUNS)
Jupiter Neurosciences Statistics
Share Statistics
Jupiter Neurosciences has 33.1M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 33.1M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 8.33K |
| FTD / Avg. Volume | 3.8% |
Short Selling Information
The latest short interest is 191.53K, so 0.58% of the outstanding shares have been sold short.
| Short Interest | 191.53K |
| Short % of Shares Out | 0.58% |
| Short % of Float | 1.13% |
| Short Ratio (days to cover) | 2.77 |
Valuation Ratios
The PE ratio is -126.24 and the forward PE ratio is null. Jupiter Neurosciences's PEG ratio is 2.9.
| PE Ratio | -126.24 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 8.8 |
| PB Ratio | 73.82 |
| P/FCF Ratio | -78.75 |
| PEG Ratio | 2.9 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Jupiter Neurosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.31 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | - |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-609.91K |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -83.5% in the last 52 weeks. The beta is -9.92, so Jupiter Neurosciences's price volatility has been lower than the market average.
| Beta | -9.92 |
| 52-Week Price Change | -83.5% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 47.28 |
| Average Volume (20 Days) | 219.29K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -2.44M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.08 |
Balance Sheet
The company has 3.77M in cash and 217.76K in debt, giving a net cash position of 3.55M.
| Cash & Cash Equivalents | 3.77M |
| Total Debt | 217.76K |
| Net Cash | 3.55M |
| Retained Earnings | -26.02M |
| Total Assets | 6.2M |
| Working Capital | 2.64M |
Cash Flow
In the last 12 months, operating cash flow was -3.91M and capital expenditures 0, giving a free cash flow of -3.91M.
| Operating Cash Flow | -3.91M |
| Capital Expenditures | 0 |
| Free Cash Flow | -3.91M |
| FCF Per Share | -0.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JUNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for JUNS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -0.94 |
| Piotroski F-Score | 2 |